New RNA-based treatments for ALS are being explored by a collaborative effort between Boston Children's Hospital and MIT. The initiative, dubbed Co-Scientist, aims to leverage biological toolkits to accelerate research into novel therapeutic approaches for neurodegenerative diseases. This work could offer new avenues for understanding and potentially treating conditions like ALS.
Opening Kapyn…